mAbxience | News

Top-level panel session at
Biolatam 2015 on biosimilars

At Biolatam 2015, to be held in Santiago, Chile, on 16 and 17 November, mAbxience will host a panel session aimed at health professionals, authorities and the industry in general to take an in-depth look at the significance of the introduction and increasingly widespread use of biosimilars.

To discuss this issue, and the latest developments in the sector, mAbxience will be assisted by experts of the calibre of Claudia Patricia Vaca González, lecturer in pharmacy at the National University of Colombia and advisor to the Colombian Ministry of Health, Fernando de Mora, lecturer at the Department of Pharmacology, Therapeutics and Toxicology at the Autonomous University of Barcelona and an expert in developing and marketing biosimilars, Stephan Jarpa, General Manger in House Consulting, Vice chairman of Chilean Association of Biotechnology Companies (ASEMBIO) and professor at the University of Valparaiso, Chile and Mauricio Seigelchifer, Tech Transfer Director for mAbxience, researcher and full member of the United States Pharmacopeial (USP) Convention Expert Committee for biological products. Specific time will also be devoted to hearing about the current situation regarding biosimilars in Latin America and the exacting and challenging process of developing a biosimilar, using the example Rituximab.